Antibiotics and BCG
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Alexandroff A, Jackson A, ODonnell M, JAMES K
. BCG immunotherapy of bladder cancer: 20 years on. Lancet. 1999; 353(9165):1689-94.
DOI: 10.1016/S0140-6736(98)07422-4.
View
2.
Redelman-Sidi G, Glickman M, Bochner B
. The mechanism of action of BCG therapy for bladder cancer--a current perspective. Nat Rev Urol. 2014; 11(3):153-62.
DOI: 10.1038/nrurol.2014.15.
View
3.
Dethlefsen L, Relman D
. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2010; 108 Suppl 1:4554-61.
PMC: 3063582.
DOI: 10.1073/pnas.1000087107.
View
4.
Wolfe A, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M
. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012; 50(4):1376-83.
PMC: 3318548.
DOI: 10.1128/JCM.05852-11.
View
5.
Kamat A, Flaig T, Grossman H, Konety B, Lamm D, ODonnell M
. Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer. Nat Rev Urol. 2015; 12(4):225-35.
DOI: 10.1038/nrurol.2015.58.
View